Onychomycosis accounts for one third of fungal skin infections. Because only about one half of nail dystrophies are caused by fungus, the diagnosis should be confirmed by potassium hydroxide preparation, culture or histology before treatment is started. Newer, more effective antifungal agents have made treating onychomycosis easier. Terbinafine and itraconazole are the therapeutic agents of choice. Although the U.S. Food and Drug Administration has not labeled fluconazole for the treatment of onychomycosis, early efficacy data are promising. Continuous oral terbinafine therapy is most effective against dermatophytes, which are responsible for the majority of onychomycosis cases. Intermittent pulse dosing with itraconazole is as safe and effective as short-term continuous therapy but more economical and convenient. With careful monitoring, patients treated with the newer antifungal agents have a good chance of achieving relief from onychomycosis and its complications.
Prescribing Patterns of Onychomycosis Therapies in the United
Onychomycosis to Fungal Superinfection: Prevention Strategies and Considerations - JDDonline - Journal of Drugs in Dermatology
IJERPH, Free Full-Text
Nail Fungus Treatment Kit for Toenail Fungus Treatment
Oveallgo™ LifeMed Home Use Onychomycosis Fungal Laser Treatment
Understanding Onychomycosis: Nail Fungal Infection Treatment
Fungal Toenail: Symptoms, Causes & Treatment
Current treatment of onychomycosis - Indian Journal of Dermatology
Fungal Nail Treatment Surgery Perth Toenail Fungus Treatment
Clinical signs of onychomycosis. a Subungual hyperkeratosis, b
Clinical Trial Designs for Topical Antifungal Treatments of
